Ado-trastuzumab emtansine (T-DM1) treatment results in grade 3-4 thrombocytopenia in 8%-13% of patients. Prior in vitro studies reported T-DM1 inhibition of megakaryocyte maturation as the cause of ...
COVID-19 triggers hyperactivity in platelets leading to the formation of more blood clots in some patients. Photo credit: Getty Images Changes in blood platelets triggered by COVID-19 could contribute ...
COLUMBUS, Ohio – It might be possible to grow human blood platelets in the laboratory for transfusion, according to a new study at The Ohio State University Medical Center. The findings, published in ...
The lives of many cancer patients are saved by the transfusion of platelets, but there is a chronic shortage of these fragile blood-clotting components because of spoilage. A new technique may double ...
Managing drug dosage is critical to the overall success of pharmaceutical intervention, not only in the clinic but also in clinical trials. Inadequate dose management of certain drugs can have fatal ...
SAN ANTONIO, Nov. 10, 2025 – A simple blood test for platelet activity at middle age could one day help identify people at risk for Alzheimer’s disease decades ahead of time, allowing for possible ...
Chronic liver disease gets worse when the liver's immune system stays overactive, resulting in ongoing inflammation and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback